...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
Reply New Message
Back To Forum List View
Icon president Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
3
BearDownAZ
Oct 05, 2020 08:24AM
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
3
noretreat
Oct 05, 2020 09:50AM
Re: Zenith Epigenetics Announces Collaboration with ... BMS = Bristol Myers Squibb = deep pockets
6
Payzone
Oct 05, 2020 12:27PM
Re: Zenith Epigenetics Announces Collaboration with ... BMS = Bristol Myers Squibb = deep pockets
2
Telepanel
Oct 05, 2020 12:34PM
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
5
fuzzyjr
Oct 05, 2020 03:01PM
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
3
KOO-KOO2
Oct 05, 2020 04:43PM
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
3
fuzzyjr
Oct 05, 2020 05:10PM

3-5 years is likely a minimum.

oncology.

 

1 Recommendations
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
4
SanFrancisco99
Oct 05, 2020 06:41PM
Icon president Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
6
Toinv
Oct 05, 2020 07:08PM
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
3
fuzzyjr
Oct 06, 2020 03:38PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply